학술논문

Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8
Document Type
Conference Paper
Source
In: Breast. (Breast, December 2023, 72)
Subject
Language
English
ISSN
15323080
09609776